These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20923403)

  • 1. The leptin system: a potential target for sepsis induced immune suppression.
    Tschöp J; Dattilo JR; Prakash PS; Kasten KR; Tschöp MH; Caldwell CC
    Endocr Metab Immune Disord Drug Targets; 2010 Dec; 10(4):336-47. PubMed ID: 20923403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cannabinoid 2 receptor as a potential therapeutic target for sepsis.
    Kasten KR; Tschöp J; Tschöp MH; Caldwell CC
    Endocr Metab Immune Disord Drug Targets; 2010 Sep; 10(3):224-34. PubMed ID: 20509835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS leptin action modulates immune response and survival in sepsis.
    Tschöp J; Nogueiras R; Haas-Lockie S; Kasten KR; Castañeda TR; Huber N; Guanciale K; Perez-Tilve D; Habegger K; Ottaway N; Woods SC; Oldfield B; Clarke I; Chua S; Farooqi IS; O'Rahilly S; Caldwell CC; Tschöp MH
    J Neurosci; 2010 Apr; 30(17):6036-47. PubMed ID: 20427662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis-induced immunosuppression: from bad to worse.
    Reddy RC; Chen GH; Tekchandani PK; Standiford TJ
    Immunol Res; 2001; 24(3):273-87. PubMed ID: 11817325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-induced hyperleptinemia improves survival and immune response in a murine model of sepsis.
    Siegl D; Annecke T; Johnson BL; Schlag C; Martignoni A; Huber N; Conzen P; Caldwell CC; Tschöp J
    Anesthesiology; 2014 Jul; 121(1):98-114. PubMed ID: 24595112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression in sepsis.
    Lyn-Kew K; Standiford TJ
    Curr Pharm Des; 2008; 14(19):1870-81. PubMed ID: 18691098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical sepsis: dysregulation of immune function and therapeutic implications.
    Boontham P; Chandran P; Rowlands B; Eremin O
    Surgeon; 2003 Aug; 1(4):187-206. PubMed ID: 15570763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged REM sleep restriction induces metabolic syndrome-related changes: Mediation by pro-inflammatory cytokines.
    Venancio DP; Suchecki D
    Brain Behav Immun; 2015 Jul; 47():109-17. PubMed ID: 25532784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis: From Historical Aspects to Novel Vistas. Pathogenic and Therapeutic Considerations.
    Magrone T; Jirillo E
    Endocr Metab Immune Disord Drug Targets; 2019; 19(4):490-502. PubMed ID: 30857516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin Protects Against Mortality and Organ Dysfunction in A Two-Hit Trauma/Sepsis Model and is IL-6-Dependent.
    Negrin LL; Jahn A; van Griensven M
    Shock; 2017 Jul; 48(1):130-137. PubMed ID: 28114167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host response biomarkers in the diagnosis of sepsis: a general overview.
    Parlato M; Cavaillon JM
    Methods Mol Biol; 2015; 1237():149-211. PubMed ID: 25319788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-modulating interventions in critically ill septic patients: pharmacological options.
    Toft P; Tønnesen E
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):491-501. PubMed ID: 22114858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis.
    Deng HP; Chai JK
    Int Immunopharmacol; 2009 Oct; 9(11):1251-9. PubMed ID: 19647101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin inhibitors from fungal endophytes (LIFEs): Will be novel therapeutic drugs for obesity and its associated immune mediated diseases.
    Chandra Mouli K; Pragathi D; Naga Jyothi U; Shanmuga Kumar V; Himalaya Naik M; Balananda P; Suman B; Seshadri Reddy V; Vijaya T
    Med Hypotheses; 2016 Jul; 92():48-53. PubMed ID: 27241254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new normal: immunomodulatory agents against sepsis immune suppression.
    Hutchins NA; Unsinger J; Hotchkiss RS; Ayala A
    Trends Mol Med; 2014 Apr; 20(4):224-33. PubMed ID: 24485901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Host inflammatory and anti-inflammatory response during sepsis].
    Adib-Conquy M; Cavaillon JM
    Pathol Biol (Paris); 2012 Oct; 60(5):306-13. PubMed ID: 22542429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis.
    Delsesto D; Opal SM
    Contrib Microbiol; 2011; 17():137-156. PubMed ID: 21659751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toll-like receptors and their role in regulation of the inflammatory response in sepsis].
    Krawczyk-Michalak K; Glapiński A; Brzezińska-Błaszczyk E
    Anestezjol Intens Ter; 2008; 40(4):253-59. PubMed ID: 19517667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase 2 enhances the survival of mice during Salmonella Typhimurium infection-induced sepsis by increasing reactive oxygen species, inflammatory cytokines and recruitment of neutrophils to the peritoneal cavity.
    Yadav S; Pathak S; Sarikhani M; Majumdar S; Ray S; Chandrasekar BS; Adiga V; Sundaresan NR; Nandi D
    Free Radic Biol Med; 2018 Feb; 116():73-87. PubMed ID: 29309892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine storm and sepsis disease pathogenesis.
    Chousterman BG; Swirski FK; Weber GF
    Semin Immunopathol; 2017 Jul; 39(5):517-528. PubMed ID: 28555385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.